Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
NCT00257426
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
DRUG:
octreotide acetate
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
[object Object]